PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Nifedipine - Angina

PAD Profile : Nifedipine - Angina Important

Keywords :
Branded prescribing, prescribing by brand, branded generics
Brand Names Include :
Adalat retard, Adalat LA, Adipine MR, Adipine XL, Coracten SR, Coracten XL, Nifedipress MR, Tensipin
Important Information :
Prescribe by BRAND.

Traffic Light Status

Status 1 of 2.

Status :
Green
Important
Formulations :
  • Modified release tablets
Important Information :
Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Green
Important
Formulations :
  • Modified release capsules
Important Information :
Coracten SR (Twice daily) and Coracten XL (once daily) are the preferred capsule brands.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
02 October 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

It is recommended that slow-release and longer-acting nifedipine products are prescribed by brand.

The preferred brands for use in primary care have been updated following the discontinuation of Adipine MR in August 2024. 

The recommendations are now:

TWICE DAILY

  • Coracten SR capsules OR
  • Tensipine MR for patients preferring a tablet

ONCE DAILY

  • Coracten XL capsules OR
  • Adipine XL for patients preferring a tablet

Associated BNF Codes

02. Cardiovascular System
02.06.02. Calcium-channel blockers
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More